MFDS — authorised 8 December 2015
- Marketing authorisation holder: Baxalta US Inc.
- Status: likely_approved
🇰🇷 Vonvendi in South Korea
MFDS authorised Vonvendi on 8 December 2015
Marketing authorisation
Vonvendi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Vonvendi approved in South Korea?
Yes. MFDS authorised it on 8 December 2015.
Who is the marketing authorisation holder for Vonvendi in South Korea?
Baxalta US Inc. holds the South Korean marketing authorisation.